跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MELPHALAN FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MELPHALAN FOR INJECTION
Authorized
STANDARD
MELPHALAN FOR INJECTION
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2e0d40ed8ba63b3b
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
2e0d40ed8ba63b3b
Drug Approval Canada Name
MELPHALAN FOR INJECTION
Product Name
MELPHALAN FOR INJECTION
Status
Marketed
Status Date
2018-06-18
Original Market Date
2018-06-18
Din
02473348
Drug Class
Human
Dosage Form
Solution , Powder For Solution , Kit
Route Of Administration
Intravenous , Intra-Arterial
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01AA03 MELPHALAN
Atc Name
l 01 aa 03
Aig Number
0225962001
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
BUFFER SOLUTION
10 ML / VIAL
MELPHALAN (MELPHALAN HYDROCHLORIDE)
50 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2e0d40ed8ba63b3b
Type
Standard
Back to Health Canada Approvals